Spanish Pharmaceuticals & Biotech Profitable Climbers

Pharma Mar

Market Cap: €1.3b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, China, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Labiana Health

Market Cap: €34.3m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally.

Almirall

Market Cap: €2.8b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Pangaea Oncology

Market Cap: €59.4m

A medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries.

Grifols

Market Cap: €6.9b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.3b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.